420 related articles for article (PubMed ID: 29656200)
21. Synthesis, biological evaluation of novel iridium(III) complexes targeting mitochondria toward melanoma B16 cells.
Yuan Y; Zhang Y; Chen J; Huang C; Liu H; Li W; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2023 Feb; 247():115046. PubMed ID: 36577214
[TBL] [Abstract][Full Text] [Related]
22. DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes.
Zhang Y; Zhou Y; Zhang H; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Nov; 224():111580. PubMed ID: 34438219
[TBL] [Abstract][Full Text] [Related]
23. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
[TBL] [Abstract][Full Text] [Related]
24. Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes.
Gu Y; Wen H; Bai L; Zhou Y; Zhang H; Tian L; Zhang Y; Hao J; Liu Y
J Inorg Biochem; 2020 Nov; 212():111215. PubMed ID: 32919250
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization and irradiation enhances anticancer activity of liposome-loaded iridium(III) complexes.
Tian S; Nie Q; Chen H; Liang L; Hu H; Tang S; Yang J; Liu Y; Yin H
J Inorg Biochem; 2024 Jul; 256():112549. PubMed ID: 38579631
[TBL] [Abstract][Full Text] [Related]
27. Iridium(III) complexes inhibit the proliferation and migration of BEL-7402 cells through the PI3K/AKT/mTOR signaling pathway.
Chen J; Liu H; Chen Y; Hu H; Huang C; Wang Y; Liang L; Liu Y
J Inorg Biochem; 2023 Apr; 241():112145. PubMed ID: 36709684
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and evaluation of anticancer activity of ruthenium (II) polypyridyl complexes.
Tang B; Wan D; Lai SH; Yang HH; Zhang C; Wang XZ; Zeng CC; Liu YJ
J Inorg Biochem; 2017 Aug; 173():93-104. PubMed ID: 28511064
[TBL] [Abstract][Full Text] [Related]
29. Enhanced in vitro cytotoxicity and antitumor activity in vivo of iridium(III) complexes liposomes targeting endoplasmic reticulum and mitochondria.
Li W; Wu X; Liu H; Shi C; Yuan Y; Bai L; Liao X; Zhang Y; Liu Y
J Inorg Biochem; 2022 Aug; 233():111868. PubMed ID: 35636300
[TBL] [Abstract][Full Text] [Related]
30. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of iridium(III) complexes on antineoplastic activity against human gastric carcinoma SGC-7901 cells.
Tian L; Zhang Y; Zhang H; Zhou Y; Li W; Yuan Y; Hao J; Yang L; Liu Y
J Biol Inorg Chem; 2021 Sep; 26(6):705-714. PubMed ID: 34448071
[TBL] [Abstract][Full Text] [Related]
32. Light activation of iridium(III) complexes driving ROS production and DNA damage enhances anticancer activity in A549 cells.
Li W; Shi C; Wu X; Zhang Y; Liu H; Wang X; Huang C; Liang L; Liu Y
J Inorg Biochem; 2022 Nov; 236():111977. PubMed ID: 36030672
[TBL] [Abstract][Full Text] [Related]
33. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis, and Anticancer Effect Studies of Iridium(III) Polypyridyl Complexes against SGC-7901 Cells.
Zhang LX; Gu YY; Wang YJ; Bai L; Du F; Zhang WY; He M; Liu YJ; Chen YZ
Molecules; 2019 Aug; 24(17):. PubMed ID: 31466318
[TBL] [Abstract][Full Text] [Related]
35. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Chen L; Tang H; Chen W; Wang J; Zhang S; Gao J; Chen Y; Zhu X; Huang Z; Chen J
J Inorg Biochem; 2023 Dec; 249():112397. PubMed ID: 37844533
[TBL] [Abstract][Full Text] [Related]
37. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
38. Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
Ye RR; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2016 Aug; 45(33):13042-51. PubMed ID: 27139504
[TBL] [Abstract][Full Text] [Related]
39. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
40. Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction.
Liao C; Xu D; Liu X; Fang Y; Yi J; Li X; Guo B
Int J Nanomedicine; 2018; 13():4417-4431. PubMed ID: 30104875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
